Haemostat 250 mg Tablets: Anti-fibrinolytic & Haemostatics


Each tablet contains ethamsylate 250 mg.


Ethamsylate is absorbed from the gastro-intestinal tract when given orally. It produce its effect within one hour.

It is excreted unchanged mainly in the urine, some appears in the faeces and bile.


  • For the prophylaxis and control of haemorhage due to rupture of small blood vessels in surgery.
  • For treatment of clinical conditions such as haematemesis, haematuria and menorrhagia.

Drug interactions

High molecular weight plasma expanders may be given after but not before ethamsylate ingestion.


Prophylactic dose. 750-1000 mg. (3-4 tablets).
Therapeutic dose.
  • Initially 750 – 1000 mg. by injection, followed by
  • maintenance dose 2 tablets every 4 – 6 hours.
Children dose. One tablet every 4 – 6 hours.


Pack of 20, 200, 1000 tablets in 2 ,20 and 100 strips, respectively, each of 10 tablets.


  • Store at temperature not exceeding 30°C.
  • Keep in dry place, protect from light.
  • Keep out of reach of children.
  • Medicament is a product which affects your health, and its consumption contrary to instructions is dangerous for you.
  • Follow strictly the doctor’s prescription, the method of use and the instructions of the pharmacist who sales the medicament.
  • The doctor and the pharmacist are experts in medicine. It’s benefits and risks.
  • Do not by yourself interrupt the period of treatment prescribed for you.
  • Do not repeat the same prescription without consulting your doctor.
  • Keep medicament out of children reach.

Council of Arab Health Ministers and Union of Arab Pharmacists

Produced by: El Nasr Pharmaceutical Chemicals Co. “ADWIC” Abu-Zaabal – A.R.E.. ATC Code: B02BX01